Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- Locally Advanced or Metastatic Solid Tumors
- Interventions
- Drug: Combination of PTT-936 and anti-PD-1/L1 therapy
- First Posted Date
- 2024-02-06
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Pyrotech Therapeutics, Inc.
- Target Recruit Count
- 68
- Registration Number
- NCT06244992
- Locations
- 🇺🇸
Precision NextGen Oncology and Research Center, Beverly Hills, California, United States
🇺🇸D&H Cancer Research Center, Margate, Florida, United States
🇺🇸The START Center, San Antonio, Texas, United States
News
No news found